US › Healthcare

Rockwell Medical Inc (RMTI)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$7.91+1.41%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$17.8M

Revenue YoY

+10.6%

Net profit

$-1.2M

EPS

$-0.34

EPS estimate

$-0.17

Net margin

-6.6%

EPS came in at -0.34 against a street estimate of -0.17 — a miss of 100.0%.

Key statistics

Market cap

$32.1M

Forward P/E

18.5

P/B

0.91

Book value

$8.83

EPS (TTM)

$-1.32

52-week high

$17.20

52-week low

$4.88

50-day MA

$7.08

200-day MA

$8.45

Beta

1.64

Analyst view

Analysts rate Rockwell Medical Inc a buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $20.00.

Shareholding

Insiders

14.80%

Institutions

8.52%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	2.93%
Renaissance Technologies Corp	1.59%
Geode Capital Management, LLC	1.06%
BlackRock Inc	0.59%
Vanguard Fiduciary Trust Co	0.57%
UBS Group AG	0.44%
Sontag Advisory LLC	0.38%
Northern Trust Corp	0.26%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Rockwell Medical Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.